Chimeric Therapeutics Statistics
Total Valuation
CHMMF has a market cap or net worth of 5.21 million. The enterprise value is 1.98 million.
| Market Cap | 5.21M |
| Enterprise Value | 1.98M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 893.61M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +84.50% |
| Shares Change (QoQ) | +20.56% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.46B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.13 |
| PB Ratio | 1.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.18 |
| EV / Sales | 1.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.70
| Current Ratio | 0.70 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -206.88 |
Financial Efficiency
Return on equity (ROE) is -180.09% and return on invested capital (ROIC) is -111.60%.
| Return on Equity (ROE) | -180.09% |
| Return on Assets (ROA) | -48.71% |
| Return on Invested Capital (ROIC) | -111.60% |
| Return on Capital Employed (ROCE) | -209.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.00% in the last 52 weeks. The beta is 1.57, so CHMMF's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -92.00% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 20,438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHMMF had revenue of 1.26 million and -11.04 million in losses. Loss per share was -0.01.
| Revenue | 1.26M |
| Gross Profit | 1.26M |
| Operating Income | -10.94M |
| Pretax Income | -10.90M |
| Net Income | -11.04M |
| EBITDA | -10.27M |
| EBIT | -10.94M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.14 million in cash and n/a in debt, giving a net cash position of 3.14 million.
| Cash & Cash Equivalents | 3.14M |
| Total Debt | n/a |
| Net Cash | 3.14M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.68M |
| Book Value Per Share | 0.00 |
| Working Capital | -1.90M |
Cash Flow
| Operating Cash Flow | -3.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -866.08% |
| Pretax Margin | -862.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CHMMF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.50% |
| Shareholder Yield | -84.50% |
| Earnings Yield | -211.67% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CHMMF has an Altman Z-Score of -7.58. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.58 |
| Piotroski F-Score | n/a |